Corcept Therapeutics Incorporated.Corcept Therapeutics Incorporated.Corcept Therapeutics Incorporated.

Corcept Therapeutics Incorporated.

No trades
See on Supercharts

Price target

116.120.000.00%
The 4 analysts offering 1 year price forecasts for HTD have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings to HTD in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


HTD EPS for the last quarter is 0.25 EUR despite the estimation of 0.16 EUR. In the next quarter EPS is expected to reach 0.14 EUR. Track more of Corcept Therapeutics Incorporated. financials and stay on top of what is up with the company.
In the next quarter Corcept Therapeutics Incorporated. revenue is expected to reach ‪192.28 M‬ EUR. Check out Corcept Therapeutics Incorporated. revenue and earnings and make informed decisions.
According to analysts, HTD price target is 116.12 EUR with a max estimate of 125.18 EUR and a min estimate of 104.46 EUR. Check if this forecast comes true in a year, meanwhile watch Corcept Therapeutics Incorporated. stock price chart and keep track of the current situation with HTD news and stock market news.
We've gathered opinions of 5 analysts rating HTD stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.